Amphenol Corporation (APH): A 28% Potential Upside in Electronic Components
Amphenol Corporation (APH): Robust Revenue Growth and a 21% Upside Potential Make This Tech Stock a Compelling Buy
Alliance Pharma reports mixed FY2024 results
Alliance Pharma plc (LON: APH) reports a 1% drop in FY 2024 revenues, but with strong gains in Kelo-Cote, MacuShield, and Hydromol segments.
Amphenol Corporation Share Price Target ‘$72.60’, now 10.7% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 10.7% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 10.8% Upside Potential
Amphenol Corporation Share Price Target ‘$72.73’, now 10.3% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 17.6% Upside Potential
Amphenol Corporation Share Price Target ‘$73.29’, now 18.4% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 10.0% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 11.2% Upside Potential
Amphenol Corporation Share Price Target ‘$73.23’, now 17.9% Upside Potential
Amphenol Corporation Share Price Target ‘$73.07’, now 18.3% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 10.2% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 2.6% Upside Potential
Amphenol Corporation Share Price Target ‘$70.33’, now 3.7% Upside Potential
Amphenol Corporation Share Price Target ‘$70.33’, now 4.1% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and 4.2% Upside Potential
Amphenol Corporation Share Price Target ‘$70.33’, now 2.8% Upside Potential
Amphenol Corporation – Consensus ‘buy’ rating and -2.5% Downside Potential